Literature DB >> 24506497

Autonomic dysfunction assessed by EZSCAN and subclinical atherosclerosis.

Jichao Sun1, Yinfei Zhang, Baihui Xu, Xiaofei Lv, Lin Ding, Ying Chen, Wanwan Sun, Jieli Lu, Min Xu, Yufang Bi, Guang Ning.   

Abstract

BACKGROUND: The present study aimed to explore the association between autonomic dysfunction and measurements of atherosclerosis in a middle-aged and elderly Chinese population.
METHODS: A population-based cross-sectional study was performed in Shanghai, China, from March to August 2010, with 5076 participants included in the analysis. Autonomic function was assessed by a novel EZSCAN test based on sudomotor function analysis. Carotid intima-media thickness (CIMT) was measured using B-mode ultrasonography and brachial-ankle pulse wave velocity (ba-PWV) was measured using an autonomic device. Participants were divided into three groups based on EZSCAN values: Group 1: EZSCAN 0-24; Group 2, EZSCAN 25-49; and Group 3, EZSCAN 50-100. These groups denoted autonomic dysfunction risk groups as follows: no risk, moderate risk and high risk, respectively.
RESULTS: The prevalence of elevated CIMT and ba-PWV increased markedly with increasing EZSCAN values (elevated CIMT 7.4%, 17.5%, and 29.7%, elevated ba-PWV 3.2%, 19.7%, and 36.5%, in Groups 1, 2, and 3, respectively; both Ptrend < 0.0001). Logistic regressions revealed that EZSCAN values ≥50 were associated with a non-significantly higher risk of elevated CIMT (odds ratio [OR] = 1.43; 95% confidence interval [CI] 0.98-2.07) and a significantly higher risk of elevated ba-PWV (OR = 2.16; 95% CI 1.25-3.71) compared with EZSCAN values <25, after controlling for conventional risk factors.
CONCLUSION: A higher EZSCAN value (≥50), an index of high autonomic dysfunction risk, was associated with an increased risk of elevated ba-PWV and CIMT. Such associations were partially explained by traditional atherosclerotic risk factors.
© 2014 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  EZSCAN test; atherosclerosis; autonomic dysfunction; brachial-ankle pulse wave velocity; carotid intima-media thickness; 关键词:动脉粥样硬化,自主神经紊乱,肱踝脉搏波传导速度,颈动脉内中膜厚度,EZSCAN 检测

Mesh:

Substances:

Year:  2014        PMID: 24506497     DOI: 10.1111/1753-0407.12135

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


  5 in total

1.  Insulin Resistance is Associated With Total Bile Acid Level in Type 2 Diabetic and Nondiabetic Population: A Cross-Sectional Study.

Authors:  Wanwan Sun; Di Zhang; Zhengyi Wang; Jichao Sun; Baihui Xu; Ying Chen; Lin Ding; Xiaolin Huang; Xiaofei Lv; Jieli Lu; Yufang Bi; Qinyi Xu
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 2.  EZSCAN for undiagnosed type 2 diabetes mellitus: A systematic review and meta-analysis.

Authors:  Antonio Bernabe-Ortiz; Andrea Ruiz-Alejos; J Jaime Miranda; Rohini Mathur; Pablo Perel; Liam Smeeth
Journal:  PLoS One       Date:  2017-10-30       Impact factor: 3.240

3.  Negative Risk Markers for Cardiovascular Risk Evaluation in Chinese Adults.

Authors:  Lizhan Bie; Jingya Niu; Shujing Wu; Ruizhi Zheng; Min Xu; Jieli Lu; Tiange Wang; Zhiyun Zhao; Shuangyuan Wang; Hong Lin; Meng Dai; Di Zhang; Yuhong Chen; Yufang Bi; Weiqing Wang; Guang Ning; Mian Li; Yu Xu
Journal:  Front Cardiovasc Med       Date:  2022-03-15

4.  The Association and Predictive Ability of ECG Abnormalities with Cardiovascular Diseases: A Prospective Analysis.

Authors:  Jingya Niu; Chanjuan Deng; Ruizhi Zheng; Min Xu; Jieli Lu; Tiange Wang; Zhiyun Zhao; Yuhong Chen; Shuangyuan Wang; Meng Dai; Yu Xu; Weiqing Wang; Guang Ning; Yufang Bi; Mian Li
Journal:  Glob Heart       Date:  2020-09-01

5.  Association of serum stromal cell-derived factor 1 levels with EZSCAN score and its derived indicators in patients with type 2 diabetes.

Authors:  Wang-Shu Liu; Ling-Yan Hua; Su-Xiang Zhu; Feng Xu; Xue-Qin Wang; Chun-Feng Lu; Jian-Bin Su; Feng Qi
Journal:  Endocr Connect       Date:  2022-04-26       Impact factor: 3.221

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.